scholarly journals Rare agressive form of giant-cell granuloma: a three years follow-up case report and discussion about medical therapeutic solutions

2018 ◽  
Vol 24 (4) ◽  
pp. 187-191
Author(s):  
Grégoire Huguet ◽  
Benoît Piot ◽  
Elisabeth Cassagnau ◽  
Jean-François Simon ◽  
Philippe Lesclous

Introduction: Central giant cell granuloma (CGCG) is a rare and benign intraosseous lesion that usually occurs in the mandible and the maxilla. It might be aggressive. Nowadays, several treatments exist. Observation: This case report, with a three years follow-up, was about an aggressive and recurring form of CGCG exclusively managed by surgical approach. Comments: Several pharmacologic approaches are possible (intralesional injections of glucocorticoids, administration of calcitonin, alpha-2a interferon, denosumab) and could be an interesting alternative or complement to the surgical management when CGCG is aggressive, recurring, or non resectable. Conclusion: Surgical approach is the gold standard for the treatment of CGCG but sometimes, pharmacologic approaches could be proposed. According to the scientific literature, denosumab appears as a reliable and effective treatment but more prospective studies are needed.

2018 ◽  
Vol 30 (3) ◽  
pp. 1-4
Author(s):  
Ahmed Al-Qattan

Central giant cell granuloma (CGCG) is an infrequent benign bony lesion of unpredictably aggressive behavior. The precise lesion character is debatable and remains inconclusive. However, three main theories were proposed: a sensitive lesion, a kind of neoplasm, or a developmental anomaly. This is a case presentation of a 16-year-old boy with a dental history of extraction of the lower right first molar, presented to hospital with two months history of swelling in the aforementioned area after the procedure. First biopsy of the swelling was performed outside the Kingdom of Bahrain. As per histopathological findings, the swelling was described as pyogenic granuloma. Second biopsy with necessary workup was conducted in the Kingdom of Bahrain and was confirmed as central giant cell granuloma through histopathological analysis; it was removed surgically.


2019 ◽  
Vol 8 (3) ◽  
pp. 1-5
Author(s):  
Agnieszka Piotrowska-Seweryn ◽  
Krzysztof Oleś ◽  
Maciej Grajek ◽  
Mykola Chekan ◽  
Adam Maciejewski ◽  
...  

Introduction Central giant cell granuloma (CGCG) is a benign tumor-like lesion of a bone, mainly localized in mandible. It usually occurs in children and young adults under 30 y.o., predominantly in females. The etiology of the disease remains unknown. Clinically, two different types of CGCG have been distinguished – an unaggressive one, in which the granuloma grows slowly, often asymptomatically, and aggressive type which is characteristic for increased bone destruction, severe pain, large size, rapid growth, high recurrence rate and complications such as root resorption, tooth displacement or cortical bone perforation. The treatment of CGCG depends on its type. In cases of granulomas of aggressive behaviour the following therapeutic procedures have been proposed: intralesial corticosteroid injections, interferon and calcitonin therapy as well as immunotherapy with anti-bone resorptive human monoclonal antibody like denosumab. However, in most cases nonsurgical management remains insufficient. Also, local curettage of the lesion results in high risk of recurrence. Therefore, radical surgical resection, commonly combined with bone reconstruction, is the most recommended way of treatment for aggressive of CGCG. Case report The authors present a case of a 31-year-old female patient treated at the Department of Oncological and Reconstructive Surgery, Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology in Gliwice due to central giant cell granuloma of a mandible. The resection of CGCG localized in mandible on the right side together with fibular free flap reconstruction has been performed, with satisfactory aesthetic effect. Positive staining for CD68 and CD31 was found in immunohistochemic examination and expression of Ki67 marker was 13%. No complications were reported in the postoperative period. The six-month follow up revealed no recurrences. Conclusions The authors claim that radical surgical management should be performed in all patients with CGCG of aggressive behaviour. Fibular free flap is recommended for reconstruction in large bone defects. It results in tumor-free margins at the resection and satisfactory cosmetic outcome. Quality of life and facial appearance can be improved with dental implantation after certain disease-free period. A regular follow-up is essential as an element of holistic oncological process.


2020 ◽  
Vol 13 (9) ◽  
pp. e237200
Author(s):  
Kumar Nilesh ◽  
Anuj Dadhich ◽  
Rahul Patil

Central giant cell granuloma (CGCG) is an expansile osteolytic lesion of the jawbone. Conventional treatment of CGCG is surgical and vary from simple curettage to more aggressive resection of the jaw. However, surgical management is associated with drawbacks including requirement of hospitalisation and general anaesthesia, damage to vital anatomic structures and continuity defect of the mandible requiring reconstruction surgery. Use of intralesional injections of corticosteroid for the management of CGCG have been inconsistently used as an alternative non-surgical method of management of CGCG with varying success. While the use of such conservative modality over ablative surgery can significantly reduce postoperative morbidity, follow-up of such cases for a long period is important to study the possible recurrence. This paper reports successful treatment of a recurrent CGCG of posterior mandible by intralesional administration of triamcinolone acetonide in a 27-year old female patient, with long-term follow-up of 10 years.


2020 ◽  
Vol 9 (1) ◽  
pp. 73-75
Author(s):  
Jahangir Hammad ◽  
Muhammad Ayoub ◽  
Kashaf-ud-doja Tariq ◽  
Farhat Gul Babar

Central giant cell granuloma (CGCG) is a benign non odontogenic lesion of jaw that may show aggressive behavior. It is classified as aggressive and non-aggressive lesion on the basis of biological behavior and radiographic features. Central giant cell lesion is more frequent in children and young adult before the age of 30 years with female predilection, with characteristic radiological and histopathological features. Here we present a case of a 35 years old female with clinical and radiological diagnosis of central giant cell lesion in posterior mandible confirmed by histopathology. A surgical approach with regular follow up is the treatment of choice in most of the cases. Key Words: Calcitonin, Corticosteroid, Curettage, Enucleation, Giant cell lesion


Author(s):  
Mehmet Kemal Tumer ◽  
Nihat Akbulut ◽  
Emine Sebnem Kursun ◽  
Akgül Arıcı ◽  
Alper Sindel

2007 ◽  
Vol 31 (4) ◽  
pp. 257-259
Author(s):  
Mariana Passos ◽  
Rebeca Azevedo ◽  
Maria Eliza Janini ◽  
Lucianne Cople Maia

This article describes a case of central giant cell granuloma in the right posterior region of mandible in a 10- year-old girl. The lesion was removed by curettage and a histopathological examination was carried out. Clinical and radiographic follow-up showed total removal of the lesion. The importance of early diagnosis of this type of lesion is emphasized, mainly in children.


2014 ◽  
Vol 72 (4) ◽  
pp. 730-736 ◽  
Author(s):  
Rúbia da Rocha Vieira ◽  
Éder Ricardo Biasoli ◽  
Marcelo Macedo Crivelini ◽  
Glauco Issamu Miyahara

Sign in / Sign up

Export Citation Format

Share Document